Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.
Author
Myngheer, N.
Allegaert, K.
Hattersley, Andrew T.
McDonald, Timothy J.
Kramer, H.
Ashcroft, F. M.
Verhaeghe, J.
Mathieu, C.
Casteels, K.
Date
2014-12Journal
Diabetes careType
Journal ArticleCase Report
Research Support, Non-U.S. Gov't
Publisher
American Diabetes AssociationDOI
10.2337/dc14-1247Rights
Archived with thanks to Diabetes CareMetadata
Show full item recordAbstract
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (PNDM) caused by KCNJ11 (Kir6.2) mutations.